Buteyko Method for Asthmatic Children With Mouth Breathing
NCT ID: NCT02724657
Last Updated: 2017-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2016-03-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Buteyko Breathing Technique to Control Asthma in School-Age Children
NCT05390554
Buteyko vs Diaphragmatic Breathing Technique Among the Adolescents
NCT07097467
NIV Application in the Treatment of Asthmatic Children
NCT02939625
Efficacy and Safety of Increasing Doses of Inhaled Albuterol in Children With Acute Wheezing Episodes
NCT01323010
Balloon Blowing Breathing Exercise in School-age Children With Asthma.
NCT04874649
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Buteyko Method
Children will perform 6 sessions (twice a week) of treatment with the Buteyko Method.
Buteyko Method
Intervention will be held twice a week during 3 weeks.
Control
Asthma education.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Buteyko Method
Intervention will be held twice a week during 3 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks.
* Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, and tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.
Exclusion Criteria
7 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal do Rio Grande do Norte
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karla Morganna Pereira Pinto de Mendonça
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal do Rio Grande do Norte (UFRN)
Natal, Rio Grande do Norte, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1.443.588
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.